Table 2 Duration of CSU in patients with resolved disease and subgroups
Duration of CSU | Median Duration of CSU (months) | Mean Duration of CSU (months) | 6 weeks–23 months | 24–47 months | 48–71 months | 72–95 months | 96–119 months | 120 months and greater |
|---|---|---|---|---|---|---|---|---|
All Patients with Resolved CSU n = 56 (%) | 48 | 61 ± 56 | 17 (30) | 9 (16) | 11 (20) | 5 (9) | 5 (9) | 9 (16) |
Males n = 11 (%) | 33 | 51 ± 61 | 5 (45) | 1 (9) | 2 (18) | 1 (9) | 0 (0) | 2 (18) |
Females n = 45 (%) | 48 | 63 ± 55 | 12 (27) | 8 (18) | 9 (20) | 4 (9) | 5 (11) | 7 (16) |
Patients with CSU recurrence n = 15 (%) | 96 | 101 ± 68 | 3 (20) | 0 (0) | 2 (13) | 2 (13) | 3 (20) | 5 (33) |
Patients without CSU recurrence n = 41 (%) | 36 | 46 ± 43 | 14 (34.1) | 9 (22) | 9 (22) | 3 (7) | 2 (5) | 4 (10) |
Patients with angioedema n = 32 (%) | 50 | 51 ± 13 | 9 (28) | 4 (13) | 6 (19) | 2 (6) | 3 (9) | 8 (25) |
Patients without angioedema n = 24 (%) | 35 | 46 ± 44 | 8 (33) | 5 (21) | 5 (21) | 3 (13) | 2 (8) | 1 (4) |
Patients with thyroid and/or autoimmune disease n = 10 (%) | 37 | 51 ± 52 | 3 (30) | 2 (20) | 2 (20) | 2 (20) | 0 (0) | 1 (10) |
Patients without thyroid or autoimmune disease n = 46 (%) | 48 | 61 ± 57 | 14 (30) | 7 (15) | 9 (20) | 3 (7) | 5 (11) | 8 (17) |